Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Veracyte, Inc. VCYT

Set alert

Price alert · VCYT

All alert types
50.70 USD +1.70 +3.47%

As of Nov 3, 10:13 AM ET

Bid
50.50 × 2
Ask
50.82 × 2
49.88 Day range 51.07
29.46 52-week range 60.91
YTD
+20.43%
1 year
+39.09%
Open
49.95
Prev close
49.00
Mkt cap
4.08B
Vol
58.95K
Avg vol
1.30M
EPS
1.40
P/E
36.22
Div yield
0.00%
More statistics
Low
49.88
High
51.07
Forward P/E
25.22
Beta
1.96
Short ratio
6.64
Inst. own
115.10%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
44.42
200-d avg
42.82
1y target
59.73

5D chart

Chart tools
Interval
1m5m15m30m

Signals (115)
NameTimeAgo
SMA: BullishNov 3, 9:30 AM43 minutes ago
SMA: BullishNov 3, 9:30 AM43 minutes ago
MACD: Buy SignalNov 3, 9:30 AM43 minutes ago
MACD: Sell SignalNov 2, 4:00 PM18 hours ago
SMA: BearishNov 2, 3:55 PM18 hours ago
SMA: BearishNov 2, 3:55 PM18 hours ago
SMA: BullishNov 2, 3:40 PM18 hours ago
SMA: BullishNov 2, 3:40 PM18 hours ago
SMA: BearishNov 2, 3:30 PM18 hours ago
SMA: BearishNov 2, 3:25 PM18 hours ago
SMA: BullishNov 2, 3:10 PM19 hours ago
MACD: Buy SignalNov 2, 3:00 PM19 hours ago
SMA: BullishNov 2, 2:55 PM19 hours ago
MACD: Sell SignalNov 2, 2:35 PM19 hours ago
SMA: BearishNov 2, 2:25 PM19 hours ago
SMA: BearishNov 2, 2:20 PM19 hours ago
SMA: BullishNov 2, 2:10 PM20 hours ago
MACD: Buy SignalNov 2, 2:10 PM20 hours ago
SMA: BullishNov 2, 2:05 PM20 hours ago
MACD: Sell SignalNov 2, 1:40 PM20 hours ago

Newest 20 of 115.

Revenue & Expenses

Revenue by
Testing → Revenue: $493.15MRevenue → Gross Profit: $360.05MGross Profit → Net Income: $66.35MGross Profit → Selling, General & Admin: $210.95MRevenue → Cost of Revenue: $157.10MGross Profit → Research & Development: $70.81MGross Profit → Other Operating Expenses: $4.13MGross Profit → Other Expenses: $5.95MGross Profit → Income Tax: $1.85MProduct → Revenue: $14.33MBiopharmaceutical And Other → Revenue: $9.66MGross Profit$360.05MCost of Revenue$157.10MNet Income$66.35MSelling, General & Admin$210.95MResearch & Development$70.81MOther Operating Expenses$4.13MOther Expenses$5.95MIncome Tax$1.85MRevenue$517.14MTesting$493.15MProduct$14.33MBiopharmaceutical And Other$9.66M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
VCYT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
517.14M445.76M361.05M296.54M219.51M
362.53M298.14M229.68M175.68M145.11M
57.78M16.14M-85.80M-41.08M-81.90M
66.35M24.14M-74.40M-36.56M-75.56M
0.820.31-1.02-0.51-1.11

Balance sheet

Full balance sheet How to read it
VCYT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
364.23M240.63M217.33M155.00M173.95M
1.41B1.30B1.11B1.16B1.19B
96.44M124.07M70.80M81.22M91.31M
39.65M50.74M12.63M14.72M18.85M
1.31B1.18B1.04B1.08B1.10B

Cash flow

Full cash flow How to read it
VCYT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
136.31M75.10M44.22M7.54M-31.62M
-9.21M-56.27M15.11M-29.39M-739.21M
-4.22M4.90M2.84M3.49M596.32M
-9.68M-11.29M-9.96M-8.55M-5.38M
122.88M23.73M62.17M-18.36M-174.51M